TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial)

Circ Heart Fail. 2019 Jul;12(7):e005931. doi: 10.1161/CIRCHEARTFAILURE.119.005931. Epub 2019 Jul 10.

Abstract

Background: Identifying low-risk acute heart failure patients safe for discharge from the emergency department is a major unmet need.

Methods and results: A prospective, observational, multicenter pilot study targeting lower risk acute heart failure patients to determine whether hsTnT (high-sensitivity troponin T) identifies emergency department acute heart failure patients at low risk for rehospitalization and mortality. hsTnT was drawn at baseline and 3 hours. Phone follow-up occurred at 30 and 90 days. The primary end point composite of all-cause mortality, rehospitalization, and emergency department visits at 90 days (changed from 30 days because of lack of mortality events), analyzed using logistic regression. Secondary end points: 30- and 90-day all-cause mortality. hsTnT values less than the 99th percentile were defined as low hsTnT. Out of 527 enrolled patients, 499 comprised the initial analysis set. Of these, 332 had both 0- and 3-hour hsTnT drawn, of whom 319 completed 30 day follow-up. The average age was 62, 60% male, and 57% black. Median hsTnT was 26.4 ng/L (interquartile range, 15.1-44.3). There were 99 (21%) 30-day composite events, 13 (2.7%) deaths at 30 days, and 25 deaths (8.2%) at 90 days. Serial hsTnT values below the 99th percentile were not associated with a lower risk for the 90-day primary composite end point (odds ratio, 0.79; 95% CI, 0.42-1.50; P=0.4736). However, no deaths occurred in the low hsTnT group at 30 days with 1 death at 90 days.

Conclusions: hsTnT did not identify patients at low risk for the primary outcome of rehospitalization, emergency department visits, and mortality at 90 days.

Clinical trial registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02592135.

Keywords: heart failure; hospitalization; mortality; risk.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood*
  • Emergency Service, Hospital / statistics & numerical data
  • Female
  • Heart Failure / blood
  • Heart Failure / diagnosis
  • Heart Failure / mortality*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / mortality*
  • Prospective Studies
  • Risk Assessment
  • Time Factors
  • Troponin T / blood*

Substances

  • Biomarkers
  • Troponin T

Associated data

  • ClinicalTrials.gov/NCT02592135